Sam Chang, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Prokarium
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    mIR
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    virtuoso surgical
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    GLG
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (General Urology)
    Ineligible company:
    NIH
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Health Publishing (General Urology)
    Ineligible company:
    Uro Today
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    urogen
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    pfizer
    Date added:
    Date updated:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    BMS
    Date added:
    Date updated:
    02/19/2025
Return to Bladder Cancer Treatment Dilemmas: The Cases You Face and What To Do about Them Webcast (2022)